Exercise Beats Weight Loss Medication for Heart Health After Weight Loss

<>

People with severe obesity who maintain an exercise routine following significant weight loss develop healthier blood vessels and lower levels of systemic inflammation than those who rely exclusively on pharmaceutical interventions, according to a peer-reviewed study published in Nature Metabolism.

Vascular Improvements Distinct to Physical Activity

Regular exercise yielded a 6% to 7% reduction in carotid artery wall thickness among participants who had lost weight. This vascular improvement was not observed in medication-only groups.

Participants trained for roughly two and a half hours per week using moderate activities like spinning and circuit training, monitored via heart-rate devices. Researchers at the University of Copenhagen noted that while weight-loss medications effectively help sustain lower body mass, they do not replicate the cardiovascular protections provided by physical activity.

The clinical investigation followed 130 individuals with severe obesity over a one-year period after they completed a low-calorie diet regimen, shedding an average of 13.7 kilograms or 30.2 pounds.

Investigators divided the cohort into four distinct experimental arms: exercise only, the GLP-1 receptor agonist liraglutide only, a combination of exercise and liraglutide, and a placebo group. The primary endpoint focused on vascular health, measured via the thickness of the carotid artery wall—a standard clinical marker used to evaluate cardiovascular risk.

Synergistic Benefits of Combining Training and Liraglutide

According to Signe Torekov, professor at the biomedical sciences department at the University of Copenhagen, the trial demonstrates that exercise remains indispensable for vascular integrity.

Participants in the physical activity cohorts achieved measurable decreases in chronic inflammatory markers, which drive cardiovascular disease progression. Combining physical training with liraglutide yielded enhanced weight reduction and supplementary improvements in vascular function metrics, highlighting a synergistic therapeutic benefit.

Accessible Activity Protocols for Mid-Age Cohorts

The dosing and training protocols relied on accessible activity levels rather than elite athletic conditioning.

Rasmus Sandsdal, medical doctor, PhD student, and first author of the study at the University of Copenhagen, pointed out that the cohort consisted of individuals in their mid-40s who had not yet manifested clinical diabetes or overt heart disease.

Implications for Modern Pharmacotherapy and Diagnostics

While the study utilized liraglutide—an earlier-generation weight-loss medication—the findings arrive as newer agents such as semaglutide see widespread clinical adoption.

Researchers emphasize that pharmacotherapy cannot fully substitute for the physiological mechanisms stimulated by muscular contraction and aerobic conditioning. Healthcare providers managing post-weight-loss care plans are encouraged to review diagnostic screening protocols through advanced vascular diagnostic laboratories to monitor arterial health accurately.

Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice.